Nivolumab Improves Survival in Advanced Gastric/GEJ Cancer
At the 2017 Gastrointestinal Cancers Symposium, researchers presented the exciting new study that treatment with nivolumab (Opdivo) reduces the risk of death... Read More
For press inquiries about the Gastric Cancer Foundation, please contact: Mediainfo@gastriccancer.org
Together, we will defeat stomach cancer.
Together, we will defeat stomach cancer.
MORE INFODONATE